Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Are Drug-Drug Interactions Today’s Biggest Health Threat?

Posted on October 16th, 2018 by in Pharma R&D

The use of prescription medicines is sharply on the rise. Over the past decade, the number of adults taking over-the-counter medicines has sunk, while the number of prescription drug users has increased by more than 30 percent. Continue reading “Are Drug-Drug Interactions Today’s Biggest Health Threat?” »

The Delicate Balance of Drug Risks vs. Benefits

Posted on October 16th, 2018 by in Pharma R&D

For many people, taking medication is a regular part of their daily routine, and these medicines are relied upon to treat disease and improve health.  The benefits of medicines are the helpful effects you get when you use them, such as the lowering blood pressure, curing infection, or relieving pain. Continue reading “The Delicate Balance of Drug Risks vs. Benefits” »

The Value of Drug–Drug Interaction Risk Assessments

Posted on June 28th, 2017 by in Pharma R&D

Should a drug candidate move on to pre-clinical and clinical trials? It’s a question that every pharmaceutical developer must face, and the earlier they can answer it, the better in terms of use of time and effort. Continue reading “The Value of Drug–Drug Interaction Risk Assessments” »